Parasol Med Tech secures $2.75M pre-seed funding led by Harper Court Ventures, UCM Ventures, and Cardiovascular Innovation Ventures to advance its novel left atrial appendage closure system for stroke prevention.
Amount Raised
$2.75 Million
Round Type
Pre-Seed
RiversideBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Parasol Med Tech, founded by UChicago cardiologist Atman Shah, closed an oversubscribed $2.75 million pre-seed funding round to develop its next-generation left atrial appendage closure system. The system is designed to prevent stroke in patients with atrial fibrillation by conforming to patient anatomy. The round included participation from Harper Court Ventures, UCM Ventures, and Cardiovascular Innovation Ventures. Proceeds will fund R&D and testing to optimize the novel catheter and gel system.
Who to call at Parasol Medtech, and when
A new round usually means Parasol Medtech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Parasol Medtech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Parasol Medtech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Parasol Medtech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Parasol Medtech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Parasol Medtech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.